Here are updates from the past week on five orthopedic and spine device company stock reports.
Medtronic had large options trading on Dec. 29, with 16,512 call options on the company purchased, according to The Legacy. This is a 119 percent increase on the daily volume. Additionally, Vice President Richard Kuntz sold 12,855 shares at a total value of $958,211.70.
Stryker Director Ronda E. Stryker sold 28,000 shares of the company's stock on Dec. 29 for a total transaction of $2.6 million, according to a WKRB News & Analysis report. She now owns 174,605 shares, totaling $16.59 million. The company's stock spiked around Christmas when rumors resurfaced about Stryker's plan to acquire Smith & Nephew.
NuVasive shareholder Patrick Miles sold 15,000 shares of the company's stock on the open market on Dec. 24 for a total transaction of $712,800. He now owns 47,501 shares valued at around $2.2 million, according to a Ticker Report article. COO Keith Valentine earlier sold 5,893 shares on Dec. 19 for a total transaction of $281,567.54, according to a Dakota Financial News report.
Smith & Nephew shares were upgraded to "outperform" by Zacks from a neutral rating, according to a report from The Legacy. The firm has a $40.90 price target on the stock, indicating a potential upside of 6.18 percent.
K2M hit another 52-week high on Dec. 24, peaking at $23.63, according to an Equities report. The stock opened at $20.71 and closed the day at $20.53. The new high could mean "trading opportunities on either the long or short side."